Anika Therapeutics Inc (ANIK)

EBITDA

$2.72M

TTM · Period ending: · USD

ANIK logo

ANIK EBITDA

Latest reported$2.72M
ANIK TTM EBITDA (-$1.50M → $2.72M)
High-resolution chart · PNG

ANIK ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Anika Therapeutics Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
-3,684,340
-1,321,782
214,375
-1,955,360
-525,639
-99,618
1,033,346
1,633,346
2,233,346
4,100,000
4,100,000
6,400,000
5,600,000
4,000,000
3,700,000
-200,000
-500,000
-1,600,000
-2,900,000
-2,500,000
-2,800,000
-2,600,000
-1,700,000
-1,700,000
-1,300,000
-1,400,000
-1,500,000
-1,200,000
-1,300,000
-1,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.